UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 515

Sortiert nach

Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer

Journal of clinical oncology, 2012-06, Vol.30 (17), p.2102-2111

2012

Link zum Volltext

Verfügbarkeit prüfen

Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

International journal of radiation oncology, biology, physics, 2012-12, Vol.84 (5), p.1198-1205

2012

Link zum Volltext

Verfügbarkeit prüfen

Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

Journal of clinical oncology, 2008-07, Vol.26 (21), p.3582-3589

2008

Link zum Volltext

Verfügbarkeit prüfen

Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225

Journal of clinical oncology, 2009-08, Vol.27 (22), p.3684-3690

2009

Link zum Volltext

Verfügbarkeit prüfen

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

The New England journal of medicine, 2010-07, Vol.363 (1), p.24-35

2010

Link zum Volltext

Verfügbarkeit prüfen

TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence

Clinical cancer research, 2012-01, Vol.18 (1), p.290-300

2012

Link zum Volltext

Verfügbarkeit prüfen

Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer

International journal of radiation oncology, biology, physics, 2014-05, Vol.89 (1), p.13-20

2014

Link zum Volltext

Verfügbarkeit prüfen

ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1

Nature cell biology, 2014-09, Vol.16 (9), p.864

2014

Link zum Volltext

Verfügbarkeit prüfen

Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial

The lancet oncology, 2012-02, Vol.13 (2), p.172-180

2012

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

The New England journal of medicine, 2006-02, Vol.354 (6), p.567-578

2006

Link zum Volltext

Verfügbarkeit prüfen

Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22)

International journal of radiation oncology, biology, physics, 2010-04, Vol.76 (5), p.1333-1338

2010

Link zum Volltext

Verfügbarkeit prüfen

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

The lancet oncology, 2010, Vol.11 (1), p.21-28

2010

Link zum Volltext

Verfügbarkeit prüfen

Larynx Preservation Clinical Trial Design: Key Issues and Recommendations—A Consensus Panel Summary

International journal of radiation oncology, biology, physics, 2009-04, Vol.73 (5), p.1293-1303

2009

Link zum Volltext

Verfügbarkeit prüfen

Cerebrovascular Disease Risk in Older Head and Neck Cancer Patients After Radiotherapy

Journal of clinical oncology, 2008-11, Vol.26 (31), p.5119-5125

2008

Link zum Volltext

Verfügbarkeit prüfen

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

Clinical cancer research, 2015-02, Vol.21 (4), p.870-881

2015

Link zum Volltext

Verfügbarkeit prüfen

Adaptive radiotherapy for head and neck cancer—Dosimetric results from a prospective clinical trial

Radiotherapy and oncology, 2013-01, Vol.106 (1), p.80-84

2013

Link zum Volltext

Verfügbarkeit prüfen

Larynx preservation clinical trial design: Key issues and recommendations-A consensus panel summary

Head & neck, 2009-04, Vol.31 (4), p.429-441

2009

Link zum Volltext

Verfügbarkeit prüfen

Improved survival using intensity‐modulated radiation therapy in head and neck cancers: A SEER‐Medicare analysis

Cancer, 2014-03, Vol.120 (5), p.702-710

2014

Link zum Volltext

Verfügbarkeit prüfen

Candidate Dosimetric Predictors of Long-Term Swallowing Dysfunction After Oropharyngeal Intensity-Modulated Radiotherapy

International journal of radiation oncology, biology, physics, 2010-12, Vol.78 (5), p.1356-1365

2010

Link zum Volltext

Verfügbarkeit prüfen

National Cancer Database report on cancer of the head and neck: 10-Year update

Head & neck, 2009-06, Vol.31 (6), p.748-758

2009

Link zum Volltext

Verfügbarkeit prüfen

An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma

Clinical cancer research, 2013-04, Vol.19 (8), p.2208-2215

2013

Link zum Volltext

Verfügbarkeit prüfen

American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer

Journal of clinical oncology, 2006-08, Vol.24 (22), p.3693-3704

2006

Link zum Volltext

Verfügbarkeit prüfen

IMRT Reirradiation of Head and Neck Cancer—Disease Control and Morbidity Outcomes

International journal of radiation oncology, biology, physics, 2009-02, Vol.73 (2), p.399-409

2009

Link zum Volltext

Verfügbarkeit prüfen

Metabolic Tumor Volume as a Prognostic Imaging-Based Biomarker for Head-and-Neck Cancer: Pilot Results From Radiation Therapy Oncology Group Protocol 0522

International journal of radiation oncology, biology, physics, 2015-03, Vol.91 (4), p.721-729

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 515

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(421)
Mit Volltextzugriff
(448)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(512)
Japanisch
(125)
Deutsch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(333)
Life Sciences & Biomedicine
(305)
Humans
(266)
Oncology
(243)
Biological And Medical Sciences
(178)
Female
(171)
Male
(166)
Medical Sciences
(159)
Radiology, Nuclear Medicine & Medical Imaging
(153)
Middle Aged
(127)
Aged
(115)
Adult
(112)
Animals
(104)
Tumors
(100)
Radiotherapy
(99)
Hematology, Oncology And Palliative Medicine
(95)
Radiology
(90)
Head And Neck Neoplasms - Radiotherapy
(88)
Radiation
(77)
Cancer Research
(74)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer

Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis

Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

TP53 Disruptive Mutations Lead to Head and Neck Cancer Treatment Failure through Inhibition of Radiation-Induced Senescence

Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer

ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1

Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22)

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

An Epithelial―Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Larynx Preservation Clinical Trial Design: Key Issues and Recommendations—A Consensus Panel Summary

Cerebrovascular Disease Risk in Older Head and Neck Cancer Patients After Radiotherapy

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

Adaptive radiotherapy for head and neck cancer—Dosimetric results from a prospective clinical trial

Larynx preservation clinical trial design: Key issues and recommendations-A consensus panel summary

Improved survival using intensity‐modulated radiation therapy in head and neck cancers: A SEER‐Medicare analysis

Candidate Dosimetric Predictors of Long-Term Swallowing Dysfunction After Oropharyngeal Intensity-Modulated Radiotherapy

National Cancer Database report on cancer of the head and neck: 10-Year update

An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma

American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer

IMRT Reirradiation of Head and Neck Cancer—Disease Control and Morbidity Outcomes

Metabolic Tumor Volume as a Prognostic Imaging-Based Biomarker for Head-and-Neck Cancer: Pilot Results From Radiation Therapy Oncology Group Protocol 0522

Suchergebnisse filtern